ArticlePloS one2026
Family support mediates the relationship between medication adherence and quality of life among patients with hypertension in Ghana: A cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension poses significant challenges to quality of life globally. While medication adherence is essential for managing hypertension, psychosocial factors like family support may influence both adherence and quality of life. This study investigated the mediating role of family support in the relationship between medication adherence and quality of life among persons with hypertension in Ghana.
methodsA cross-sectional study was conducted among 365 patients with hypertension attending Kwame Nkrumah University of Science and Technology Hospital in Kumasi, Ghana. Data were collected using structured questionnaires, including the Short Form-36 for quality of life assessment, the Family Adaptation, Partnership, Growth, Affection, Resolve scale for family support measurement, and the Morisky Medication Adherence Scale. Mediation analysis was performed using R statistical software.
resultsFive models with increasing levels of adjustment were constructed for the mediation analysis. Higher medication adherence was significantly associated with better quality of life (Total Effect: (β) = 1.07, 95% CI: 0.63-1.50, p < 0.001). Family support significantly mediated this relationship (Average Causal Mediation Effect = 0.09, 95% CI: 0.02-0.19, p = 0.008), accounting for 8% of the total effect. The direct effect of medication adherence on quality of life remained significant after adjusting for family support (Average Direct Effect = 0.98, 95% CI: 0.52-1.42, p < 0.001). The mediation effect persisted after adjusting for socio-demographic characteristics, knowledge score, healthcare access, and lifestyle factors (mediated proportion: 8.9%, p = 0.038). Patients from highly functional families demonstrated better quality of life with a unit increase in medication adherence score.
conclusionFamily support partially mediates the relationship between medication adherence and quality of life of persons with hypertension. Interventions to improve medication adherence and quality of life should incorporate strategies to enhance family support systems. Healthcare providers should consider the complex family dynamics when developing comprehensive management plans for persons with hypertension.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.